Evidence map›Paper›PMID 28757610›Full record

ArticleCellular & molecular immunology2017

The IL-1R/TLR signaling pathway is essential for efficient CD8

Zhiyong Ma, Jia Liu, Weimin Wu, Ejuan Zhang, Xiaoyong Zhang, Qian Li, Gennadiy Zelinskyy, Jan Buer, Ulf Dittmer, Carsten J Kirschning and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Microglia and Sleep Disorders.Advances in neurobiology · 2024
    Review
  3. TRIF-dependent signaling and its role in liver diseases.Frontiers in cell and developmental biology · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Overexpression of Interleukin-1α Suppresses Liver Metastasis of Lymphoma: Implications for Antitumor Effects of CD8+ T-cells.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2021
    Article
  11. Article
  12. Review
  13. Frontiers in immunology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Zhiyong MaInstitute of Virology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Jia LiuInstitute of Virology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Weimin WuInstitute of Virology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Ejuan ZhangInstitute of Virology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Xiaoyong ZhangInstitute of Virology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Qian LiInstitute of Virology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Gennadiy ZelinskyyInstitute of Virology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Jan BuerInstitute of Medical Microbiology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Ulf DittmerInstitute of Virology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Carsten J KirschningInstitute of Medical Microbiology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
Mengji LuInstitute of Virology, University Hospital of Essen, University of Duisburg-Essen, 45122 Essen, Germany.
University of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outcome of hepatitis B viral (HBV) infection is determined by the complex interactions between replicating HBV and the immune system. While the role of the adaptive immune system in the resolution of HBV infection has been studied extensively, the contribution of innate immune mechanisms remains to be defined. Here we examined the role of the interleukin-1 receptor/Toll-like receptor (IL-1R/TLR) signaling pathway in adaptive immune responses and viral clearance by exploring the HBV mouse model. Hydrodynamic injection with a replication-competent HBV genome was performed in wild-type mice (WT) and a panel of mouse strains lacking specific innate immunity component expression. We found higher levels of HBV protein production and replication in Tlr2

Indexed as

AnimalsCD8-Positive T-LymphocytesCells, CulturedCytokinesDisease Models, AnimalHepatitis BHepatitis B virusImmunomodulationInterleukin-1 Receptor-Associated KinasesMice, Inbred C57BLMice, KnockoutMyeloid Differentiation Factor 88Receptors, Interleukin-1Signal TransductionToll-Like Receptor 2CytokinesInterleukin-1 Receptor-Associated KinasesIrak4 protein, mouseMyd88 protein, mouseMyeloid Differentiation Factor 88Receptors, Interleukin-1Tlr2 protein, mouseToll-Like Receptor 2

Identifiers

PMID28757610
PMCPMC5719144
OpenAlexW2739925500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.